Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9.
Mol Cancer Res. 2017.
PMID: 28184013
Free PMC article.
Effective binding of a phosphatidylserine-targeting antibody to Ebola virus infected cells and purified virions.
Dowall SD, Graham VA, Corbin-Lickfett K, Empig C, Schlunegger K, Bruce CB, Easterbrook L, Hewson R.
Dowall SD, et al. Among authors: schlunegger k.
J Immunol Res. 2015;2015:347903. doi: 10.1155/2015/347903. Epub 2015 Mar 1.
J Immunol Res. 2015.
PMID: 25815346
Free PMC article.
Item in Clipboard
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity.
Dowall SD, Matthews DA, Garcia-Dorival I, Taylor I, Kenny J, Hertz-Fowler C, Hall N, Corbin-Lickfett K, Empig C, Schlunegger K, Barr JN, Carroll MW, Hewson R, Hiscox JA.
Dowall SD, et al. Among authors: schlunegger k.
Genome Biol. 2014;15(11):540. doi: 10.1186/PREACCEPT-1724277741482641.
Genome Biol. 2014.
PMID: 25416632
Free PMC article.
Item in Clipboard
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody.
Dowall S, Taylor I, Yeates P, Smith L, Rule A, Easterbrook L, Bruce C, Cook N, Corbin-Lickfett K, Empig C, Schlunegger K, Graham V, Dennis M, Hewson R.
Dowall S, et al. Among authors: schlunegger k.
Antiviral Res. 2013 Feb;97(2):108-11. doi: 10.1016/j.antiviral.2012.11.003. Epub 2012 Nov 16.
Antiviral Res. 2013.
PMID: 23165089
Item in Clipboard
r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.
Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA.
Sullivan LA, et al. Among authors: schlunegger k.
PLoS One. 2010 Aug 6;5(8):e12031. doi: 10.1371/journal.pone.0012031.
PLoS One. 2010.
PMID: 20700512
Free PMC article.
Item in Clipboard
Cite
Cite